or wait 15s
Novo Nordisk has announced that Singapore's Health Sciences Authority (HSA) has approved Wegovy® (onc
Australia-based Telix Pharmaceuticals has signed a strategic agreement to lead a merger with ITM Isotope Techn
Japan-based Ono Pharmaceutical has entered into a drug discovery partnership agreement with US-based Aitia, In
The University of Melbourne has joined the Structural Genomics Consortium (SGC) with the establishment of SGC-
Researchers from Birla Institute of Technology and Science, Pilani (BITS Pilani), India and institutions in Ta
Indian biotechnology company Immunoscript Life Science will receive up to $8.9 million from Norway-based Coali
HKSH Medical Group (HKSH) and United Imaging Healthcare (United Imaging) have announced the arrival of Hong Ko
AIMD Inc., a Korean medical technology company specialising in AI-powered emergency care, has announced the gl
WuXi XDC Cayman Inc., a leading global Contract Research, Development and Manufacturing Organisation (CRDMO) f
Viral Vector Manufacturing Facility (VVMF), Australia’s first viral vector Contract Development and Manu
The Race TO GREENER PHARMA
A greener pharmaceutical industry will not be built through sustainability reports alone. It will be built in the factories where medicines are made. Across Asia-Pacific (APAC), this is becoming an increasingly important test for the industry as rising resource costs, climate risks, customer expectations and regulatory scrutiny converge. For Contract Development and Manufacturing Organisations (CDMOs), the challenge is particularly significant: the choices made on the factory floor — from energy and water use to solvents, waste, production technologies and sourcing — can determine the environmental footprint of medicines long before they reach patients. With manufacturing estimated to account for around 80 per cent of a pharmaceutical company’s environmental footprint, the stakes are high. So, what does greener pharmaceutical manufacturing actually look like in practice? We have examined the latest Environmental, Social and Governance (ESG) and sustainability reports of eight leading APAC CDMOs to find out where the industry is making real progress, and where the biggest challenges remain.
For Feedback, please email us at: coo@mmactiv.com
International Pharmaceutical Ingredients Expo And Conference 2026
Reed Exhibitions Limited
info@reedexpo.co.jp http://www.rxjapan.jp/enINTEX Osaka, Osaka, Japan
GITEX AI VIETNAM
KAOUN International
marketing@gitexvietnam.com https://gitexvietnam.com/Hanoi, Vietnam
